Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.

NCT02070211 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

22q11 Deletion Syndrome

Interventions

DIETARY_SUPPLEMENT: omega-3 PUFAs
OTHER: Standard care
DIETARY_SUPPLEMENT: placebo

Sponsor

Bambino Gesù Hospital and Research Institute

Collaborators

[object Object]
[object Object]